Wells Fargo Maintains Overweight on Gilead Sciences, Raises Price Target to $150

Benzinga · 1d ago
Wells Fargo analyst Mohit Bansal maintains Gilead Sciences (NASDAQ:GILD) with a Overweight and raises the price target from $145 to $150.